086900 — Medy Tox Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩803bn
- KR₩822bn
- KR₩229bn
Annual cashflow statement for Medy Tox, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -30,039 | 93,263 | 36,596 | 9,690 | 16,074 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 29,264 | -46,487 | 22,689 | 16,683 | 14,505 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 10,104 | -44,758 | -47,880 | -27,958 | -13,358 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 27,927 | 19,966 | 26,169 | 13,503 | 36,892 |
| Capital Expenditures | -44,306 | -21,344 | -25,101 | -37,469 | -18,723 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -7,718 | -6,433 | -11,023 | 50,724 | 18,076 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -52,024 | -27,777 | -36,124 | 13,255 | -647 |
| Financing Cash Flow Items | -2,991 | -3,648 | -2,077 | -3,794 | -4,296 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 50,718 | 34,804 | -40,388 | -13,544 | -24,048 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 23,977 | 27,784 | -51,089 | 12,558 | 12,922 |